NO982311L - Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt - Google Patents

Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt

Info

Publication number
NO982311L
NO982311L NO982311A NO982311A NO982311L NO 982311 L NO982311 L NO 982311L NO 982311 A NO982311 A NO 982311A NO 982311 A NO982311 A NO 982311A NO 982311 L NO982311 L NO 982311L
Authority
NO
Norway
Prior art keywords
methods
compositions
muscocyte
oral
prevention
Prior art date
Application number
NO982311A
Other languages
English (en)
Other versions
NO982311D0 (no
Inventor
Deborah A Steinberg
De Hwa Chao
David Loury
Roger Cherng Fu
Chee Liang Gu
Conway C Chang
John C Fiddes
Original Assignee
Intrabiotics Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intrabiotics Pharmaceuticals filed Critical Intrabiotics Pharmaceuticals
Publication of NO982311D0 publication Critical patent/NO982311D0/no
Publication of NO982311L publication Critical patent/NO982311L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dentistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pest Control & Pesticides (AREA)
  • Communicable Diseases (AREA)
  • Agronomy & Crop Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Exhaust Gas After Treatment (AREA)
  • Paints Or Removers (AREA)

Abstract

Det er beskrevet fremgangsmåter og sammensetninger egnede for behandling av oral mucositt i dyr, spesielt mennesker, med antimikrobielle peptider så som protegrin peptider.
NO982311A 1995-11-22 1998-05-20 Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt NO982311L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US56234695A 1995-11-22 1995-11-22
US64981196A 1996-05-17 1996-05-17
US69092196A 1996-08-01 1996-08-01
US08/752,852 US5994306A (en) 1995-11-22 1996-11-21 Fine-tuned protegrins
PCT/US1996/018845 WO1997018827A1 (en) 1995-11-22 1996-11-22 Compositions and methods for the prevention and treatment of oral mucositis

Publications (2)

Publication Number Publication Date
NO982311D0 NO982311D0 (no) 1998-05-20
NO982311L true NO982311L (no) 1998-07-22

Family

ID=27415886

Family Applications (2)

Application Number Title Priority Date Filing Date
NO982310A NO982310L (no) 1995-11-22 1998-05-20 Protegriner
NO982311A NO982311L (no) 1995-11-22 1998-05-20 Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO982310A NO982310L (no) 1995-11-22 1998-05-20 Protegriner

Country Status (12)

Country Link
US (1) US5994306A (no)
EP (1) EP0862448A4 (no)
JP (1) JP2001520639A (no)
KR (1) KR19990071546A (no)
CN (1) CN1251041A (no)
AU (1) AU720467B2 (no)
BR (1) BR9611565A (no)
CZ (1) CZ159198A3 (no)
HU (1) HUP0104431A2 (no)
NO (2) NO982310L (no)
PL (1) PL336763A1 (no)
WO (2) WO1997018827A1 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159936A (en) * 1993-07-20 2000-12-12 The Regents Of The University Of California Compositions and methods for treating and preventing microbial and viral infections
US6653442B1 (en) 1993-07-20 2003-11-25 Intrabiotics Pharmaceuticals, Inc. Protegrins
US6307016B1 (en) * 1995-07-06 2001-10-23 Intrabiotics Pharmaceuticals, Inc. Parevins and tachytegrins
USRE38828E1 (en) * 1995-07-06 2005-10-11 Intrabiotics Pharmaceuticals, Inc. Parevins and tachytegrins
FR2767323B1 (fr) * 1997-08-12 2001-01-05 Synt Em Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
US6043220A (en) * 1997-12-03 2000-03-28 Intrabiotics Pharmaceuticals, Inc. Threonine-containing protegrins
KR100314721B1 (ko) * 1998-01-22 2001-11-23 김일웅 생물학적 활성이 있는 신규한 펩타이드
ES2274621T3 (es) * 1998-03-12 2007-05-16 Georgetown University Peptidos que contienen una secuencia de reconocimiento del colesterol y usos de los mismos.
US7223727B2 (en) 1998-04-09 2007-05-29 Serono Genetics Institute S.A. GSSP4 polynucleotides and polypeptides and uses thereof
EP0974360A3 (en) * 1998-06-26 2000-03-29 N.V. Nutricia Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
DE69914911T2 (de) * 1998-06-26 2004-12-09 Naamloze Vennootschap Nutricia Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
JP2002519155A (ja) * 1998-07-02 2002-07-02 スティヒティング・スケルトル・ティシュー・エンジニアリング・グループ・アムステルダム 抗微生物性ペプチドを有する骨セメント
AU5006499A (en) * 1998-07-23 2000-02-14 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the treatment or prevention of pulmonary infections
US6335318B1 (en) 1999-05-10 2002-01-01 The Regents Of The University Of California Antimicrobial theta defensins and methods of using same
CA2382165A1 (en) 1999-12-08 2001-06-14 Genset S.A. Full-length human cdnas encoding potentially secreted proteins
ES2174770T1 (es) * 1999-12-21 2002-11-16 Innogenetics Nv Peptidos diseñados para el diagnostico y el tratamiento de artritis reumatoide.
BR0001870B1 (pt) * 2000-05-29 2014-02-25 Peptídeo, processo de obtenção de peptídeo, formulação compreendendo peptídeo, método de prevenção de crescimento de parasitas, fungos e bactérias, método para inativar a endotoxina de bactérias gram-negativas
GB0031425D0 (en) * 2000-12-22 2001-02-07 Amoebics Ltd Antibacterial treatments
KR100738362B1 (ko) * 2001-03-19 2007-07-12 재단법인서울대학교산학협력재단 신규한 디아민디티올 유도체 및 그의 방사성 레늄 또는방사성 테크네슘 착체； 그리고, 그의 방사성 레늄 착체와리피오돌을 포함하는 간암 치료용 조성물 및 그의 제조용키트
WO2003000277A2 (en) * 2001-06-22 2003-01-03 The Hospital For Sick Children Antimicrobial peptides
US7033991B2 (en) 2001-07-16 2006-04-25 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Inhibiting furin with polybasic peptides
WO2003062266A2 (en) * 2002-01-22 2003-07-31 Intrabiotics Pharmaceuticals, Inc. Hybrid synthetic method for antimicrobial peptides
CA2482995C (en) 2002-04-22 2013-01-29 Dow Global Technologies Inc. Low-cost production of peptides
US7119070B2 (en) * 2002-04-30 2006-10-10 The Regents Of The University Of California Antimicrobial theta defensins, analogs thereof, and methods of use
AU2003246644A1 (en) * 2002-07-08 2004-01-23 Genova, Ltd. Secreted peptides
US20080255052A1 (en) * 2004-12-23 2008-10-16 The Regents Of The University Of California Immunologic regulation by theta defensins
US7875620B2 (en) * 2005-06-30 2011-01-25 Piper Medical, Inc. Methods of treating microbial infections
WO2008030988A2 (en) 2006-09-06 2008-03-13 The Regents Of The University Of California Selectively targeted antimicrobial peptides and the use thereof
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
JP5265762B2 (ja) 2008-05-13 2013-08-14 ユニバーシティ・オブ・カンザス 金属抽出ペプチド（ｍａｐ）タグおよび関連する方法
TWI394578B (zh) * 2009-01-09 2013-05-01 Academia Sinica 抗菌蛋白之新用途
US20100202983A1 (en) * 2009-02-09 2010-08-12 Jernberg Gary R Selectively targeted antimicrobials for the treatment of periodontal disease
TWI520951B (zh) 2011-05-16 2016-02-11 塞爾西優蒂克斯公司 用於治療粘膜炎的化合物
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
WO2014052438A1 (en) 2012-09-25 2014-04-03 Regents Of The University Of Minnesota Methods for making and using antimicrobial peptides
CN103623391B (zh) * 2013-10-10 2014-12-31 中山大学 抗菌肽Protegrin-1在防治猪蓝耳病中的应用
KR20160083884A (ko) 2013-11-01 2016-07-12 스페리움 바이오메드 에스.엘. 치료제 및 미용제의 경피 전달을 위한 봉입체
CN103936827B (zh) * 2014-04-22 2015-10-14 福州大学 一种韭菜籽抗菌三肽及其制备方法与应用
CN105175509A (zh) * 2015-10-19 2015-12-23 河南科技学院 一种抗菌肽xyz-1及其应用
CN108524911B (zh) * 2018-02-27 2022-03-08 成都山信药业有限公司 Protegrin-1抗菌肽衍生物在制备抗口腔致病菌药物中的用途
AU2018445889A1 (en) * 2018-10-19 2021-05-20 Riptide Bioscience, Inc. Antimicrobial peptides and methods of using the same
US20220054562A1 (en) 2018-12-28 2022-02-24 General Probiotics, Inc. Combinations of engineered antimicrobial probiotics for treatment of gastrointestinal tract pathogens
US11771694B2 (en) 2020-06-05 2023-10-03 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections
CN113975373A (zh) * 2021-11-18 2022-01-28 宁波市眼科医院 眼用制剂

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543252A (en) * 1982-01-21 1985-09-24 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US4652639A (en) * 1982-05-06 1987-03-24 Amgen Manufacture and expression of structural genes
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US4705777A (en) * 1985-02-25 1987-11-10 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US5338724A (en) * 1986-11-26 1994-08-16 Cornell Research Foundation, Inc. Antimicrobial proteins, compositions containing same and uses thereof
US5087569A (en) * 1986-11-26 1992-02-11 Cornell Research Foundation, Inc. And The Rockefeller University Antimicrobial proteins, compositions containing same and uses thereof
US5126257A (en) * 1986-11-26 1992-06-30 Cornell Research Foundation Antimicrobial proteins, compositions containing same and uses thereof
US5032574A (en) * 1988-05-26 1991-07-16 Invitron Corporation Novel antimicrobial peptide
US5308834A (en) * 1989-02-14 1994-05-03 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and prevention thereof using a BPI protein
US5334584A (en) * 1989-02-14 1994-08-02 Incyte Pharamaceuticals, Inc. Recombinant, non-glycosylated bpi protein and uses thereof
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
US5171739A (en) * 1989-02-14 1992-12-15 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
US5102870A (en) * 1989-04-14 1992-04-07 Schering Ag Treatment and prevention of oral mucositis with growth factors
US5484885A (en) * 1989-07-05 1996-01-16 Emory University Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37
US5607916A (en) * 1989-07-05 1997-03-04 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5447914A (en) * 1990-06-21 1995-09-05 Emory University Antimicrobial peptides
US5432270A (en) * 1990-10-25 1995-07-11 Zasloff; Michael A. DNA encoding tracheal antimicrobial peptides
WO1993001723A1 (en) * 1991-07-25 1993-02-04 Magainin Pharmaceuticals, Inc. Prophylaxis and treatment of adverse oral conditions with biologically active peptides
US5488035A (en) * 1991-12-06 1996-01-30 Pioneer Hi-Bred International, Inc. Peptide with inhibitory activity towards plant pathogenic fungi
CA2136103C (en) * 1992-05-26 2004-03-30 The General Hospital Corporation Antibiotic cryptdin peptides and methods of their use
WO1994002589A1 (en) * 1992-07-17 1994-02-03 Panorama Research, Inc. Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity
US5459235A (en) * 1993-03-19 1995-10-17 The Regents Of The University Of California Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
WO1994028921A1 (en) * 1993-06-04 1994-12-22 Demeter Biotechnologies, Ltd. Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
US5693486A (en) * 1993-07-20 1997-12-02 Intrabiotics DNA sequences encoding protegrins and protegrin analogs and their use in recombinant methods of producing protegrins
US5708145A (en) * 1993-07-20 1998-01-13 University Of California Immunglobulins reactive with protegrins
US5464823A (en) * 1993-07-20 1995-11-07 The Regents Of The University Of California Mammalian antibiotic peptides
US5804558A (en) * 1993-07-20 1998-09-08 University Of California Protegrins
KR100208873B1 (ko) * 1993-10-14 1999-07-15 야마야 와따루 폴리펩타이드 및 그것으로 부터 제조된 항-hiv 제제
US5804553A (en) * 1994-04-05 1998-09-08 University Of California Prophenins - antibiotic peptides
US5589364A (en) * 1994-07-29 1996-12-31 Magainin Pharmaceuticals Inc. Recombinant production of biologically active peptides and proteins
CA2226121A1 (en) * 1995-07-06 1997-01-23 Intrabiotics Pharmaceuticals, Incorporated Parevins and tachytegrins

Also Published As

Publication number Publication date
US5994306A (en) 1999-11-30
WO1997018827A1 (en) 1997-05-29
NO982310L (no) 1998-07-22
HUP0104431A2 (hu) 2002-03-28
EP0862448A4 (en) 1999-03-31
KR19990071546A (ko) 1999-09-27
JP2001520639A (ja) 2001-10-30
AU720467B2 (en) 2000-06-01
NO982310D0 (no) 1998-05-20
CZ159198A3 (cs) 1998-10-14
AU7739496A (en) 1997-06-11
NO982311D0 (no) 1998-05-20
EP0862448A1 (en) 1998-09-09
WO1997018826A1 (en) 1997-05-29
PL336763A1 (en) 2000-07-17
BR9611565A (pt) 1999-12-28
CN1251041A (zh) 2000-04-19

Similar Documents

Publication Publication Date Title
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
GB2288732B (en) Pharmaceutical compositions
DK0751789T3 (da) Gel til behandling af hudsygdomme og til desinfektion af huden
BG100960A (en) Dosage forms for controlled release of azitromycin
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
CY1108110T1 (el) Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου
IL122248A0 (en) Use of nisin for treating an infection
ATE253351T1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
BR9610303A (pt) Composições desinfetantes sinérgicas tuberculocidade e processos de desinfecção
DE69628302D1 (de) Milchige reinigungs- und/oder desinfektionsmittelzusammensetzungenfür harte oberflächen.
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
NO982721D0 (no) Preserverende oppl°sning
NO990440L (no) Preparat som innbefatter mupirocin og klorheksidin
DK0693919T3 (da) Orale præparater til behandling af plak og gingivitis indeholdende et ikke-kationisk antibakterielt middel og et hydrogenca
TR199900505T2 (no)
WO1999067238A3 (en) Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
DE69303305D1 (de) Mittel zur Behandlung chronischer Ermüdungserscheinungen
DE69514928D1 (de) Gegen protozoen wirksamezyklische tetrapeptide
GB9505082D0 (en) Medicament
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
HUP9901183A2 (hu) Készítmények és eljárások az orális mukozitisz megakadályozására és kezelésére